MICROBION CORP

Profile

Company Names

MICROBION CORP

Addresses

5 WEST MENDENHALL STREET, SUITE 202, BOZEMAN, MT 59715

1102 W. BABCOCK STREET, SUITE B, BOZEMAN, MT 59715

910 TECHNOLOGY BOULEVARD, SUITE G, BOZEMAN, MT 59718

Phone Numbers

(406) 599-1190

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$45,718,424.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2021-01-08 
$11,890,627.00 
$13,390,627.00 
$1,500,000.00 
Equity 
5
2016-12-30 
$25,373,967.00 
$51,258,964.00 
$25,884,997.00 
Equity 
4
2014-01-08 
$5,861,141.00 
$8,500,000.00 
$2,638,859.00 
Equity 
3
2012-10-15 
$1,246,025.00 
$1,499,998.00 
$253,973.00 
Equity 
2
2010-08-01 
$932,664.00 
$2,074,999.00 
$1,142,335.00 
Equity 
1
2009-10-26 
$414,000.00 
$414,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ZAFRIRA 
 
AVNUR 
DIRECTOR
BRETT 
 
BAKER 
EXECUTIVE OFFICER, DIRECTOR
JARED 
 
CARNEY 
DIRECTOR
TOM 
 
FARQUHAR 
DIRECTOR
ROBERT 
 
GILLAM 
DIRECTOR
JASON 
 
HARMON 
DIRECTOR
FRANK 
 
KERINS 
EXECUTIVE OFFICER
ROGER 
 
KUYPERS 
DIRECTOR
KARIM 
 
LALJI 
DIRECTOR, EXECUTIVE OFFICER
JULIA 
 
LEVY 
DIRECTOR
RODGER 
 
MAY 
DIRECTOR
DONALD 
 
RIX 
DIRECTOR
STEVEN 
 
SCHELLONG 
DIRECTOR
JARRET 
 
SHA 
DIRECTOR
KALEY 
 
WILSON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-08 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#